Table 2.
Treatment | Mammary cancer incidence | Percent of rats with mammary cancer | Average number of cancers per rat |
---|---|---|---|
Control | 18/20 | 90 | 2.3 ± 0.4 |
30 mg of E plus 30 mg of P* | 1/11§ | 9 | 0.1 ± 0.1§ |
Control | 9/9 | 100 | 2.8 ± 0.1 |
30 mg of E plus 30 mg of P* | 5/10‡ | 50 | 0.6 ± 0.2§ |
Control | 9/9 | 100 | 2.8 ± 0.5 |
30 mg of E plus 30 mg of P* | 0/8 | 0 | 0§ |
Control | 10/10 | 100 | 2.8 ± 0.6 |
30 mg of E plus 30 mg of P† | 1/9 | 11 | 0.1 ± 0.1§ |
Control | 9/9 | 100 | 2.7 ± 0.5 |
200 μg of E plus 30 mg of P* | 1/10§ | 10 | 0.1 ± 0.1§ |
Rats were treated with MNU at 7 weeks of age.
Rats treated 2 weeks later with E plus P for 3 weeks.
Rats treated 4 weeks later with E plus P for 3 weeks.
P = 0.05 compared to control.
P < 0.005 compared to control.